SORRENTO THERAPEUTICS, INC.

Profile

Company Names

SORRENTO THERAPEUTICS, INC.
QUIKBYTE SOFTWARE INC

Addresses

6042 CORNERSTONE CT. WEST, SAN DIEGO, CA 92121

6042 CORNERSTONE CT. WEST, SUITE B, SAN DIEGO, CA 92121

Phone Numbers

858-210-3700
(858) 210-3700
858-205-4193

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

COLORADO

Total Amount Raised:

$19,793,495.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2013-10-21 
$1,850,000.00 
$1,850,000.00 
$0.00 
Debt 
4
2013-03-13 
$6,418,495.00 
$10,000,000.00 
$3,581,505.00 
Equity 
3
2011-12-29 
$2,000,000.00 
$2,000,000.00 
$0.00 
Equity 
2
2009-09-21 
$7,525,000.00 
$7,525,000.00 
$0.00 
Equity 
1
2009-09-18 
$2,000,000.00 
$2,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
EMST-GUNTER 
 
AFTING 
DIRECTOR
SORRENTO THERAPEUTICS, INC.
ERNST-GUENTER 
 
AFTING 
DIRECTOR
QUIKBYTE SOFTWARE INC   |  RETROTOPE, INC.
ERNST-GUNTER 
 
AFTING 
DIRECTOR
SEQUENOM INC   |  SORRENTO THERAPEUTICS, INC.
VOUNG 
 
DR. TRIEU 
EXECUTIVE OFFICER, DIRECTOR
SORRENTO THERAPEUTICS, INC.
S. 
JAMES 
FREEDMAN 
DIRECTOR
QUIKBYTE SOFTWARE INC
CAM 
 
GALLAGHER 
DIRECTOR
NERVEDA INC   |  NERVEDA LLC   |  SORRENTO THERAPEUTICS, INC.   |  KALYRA PHARMACEUTICALS, INC.   |  SG PHARMACEUTICALS, INC.   |  RETROSENSE THERAPEUTICS, LLC   |  ZAVANTE THERAPEUTICS, INC.   |  ZENO PHARMACEUTICALS, INC.   |  ONCTERNAL THERAPEUTICS, INC.   |  VELOSBIO INC.   |  OCUPHIRE PHARMA, INC.   |  OCUPHIRE PHARMA, INC.   |  SELECTION, INC.   |  OPUS GENETICS, INC.   |  ALESSA THERAPEUTICS, INC.
GLENN 
L. 
HALPRYN 
DIRECTOR
CASTLE BRANDS INC   |  QUIKBYTE SOFTWARE INC   |  CHROMADEX CORP.   |  SORRENTO THERAPEUTICS, INC.
JANE 
H. 
HSIAO, PH.D., MBA 
DIRECTOR
SORRENTO THERAPEUTICS, INC.
KIM 
 
JANDA 
DIRECTOR
SORRENTO THERAPEUTICS, INC.
KIM 
D. 
JANDA 
DIRECTOR
SORRENTO THERAPEUTICS, INC.
KIM 
 
JANDA, PH.D. 
DIRECTOR
SORRENTO THERAPEUTICS, INC.
HENRY 
 
JI 
EXECUTIVE OFFICER, DIRECTOR
SORRENTO THERAPEUTICS, INC.   |  QUIKBYTE SOFTWARE INC   |  SORRENTO THERAPEUTICS, INC.   |  CONKWEST, INC.   |  CELULARITY INC.   |  AARDVARK THERAPEUTICS, INC.   |  SCILEX HOLDING CO
HENRY 
 
JI, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
SORRENTO THERAPEUTICS, INC.   |  CONKWEST, INC.   |  NANTKWEST, INC.
CURTIS 
 
LOCKSHIN 
DIRECTOR
QUIKBYTE SOFTWARE INC   |  CHROMADEX CORP.   |  RXI PHARMACEUTICALS CORP   |  XENETIC BIOSCIENCES, INC.
CURTIS 
 
LOCKSHIN, PH.D. 
DIRECTOR
SORRENTO THERAPEUTICS, INC.   |  PHIO PHARMACEUTICALS CORP.
M. 
SCOTT 
SALKA 
DIRECTOR
SORRENTO THERAPEUTICS, INC.
SCOTT 
M 
SALKA 
DIRECTOR
SORRENTO THERAPEUTICS, INC.
ANTONIUS 
 
SCHUH 
EXECUTIVE OFFICER, DIRECTOR
SORRENTO THERAPEUTICS, INC.   |  QUIKBYTE SOFTWARE INC   |  TRANSGENOMIC INC   |  TROVAGENE INC.   |  SELECTION, INC.
JAISIM 
 
SHAH 
DIRECTOR
ZELOS THERAPEUTICS INC   |  ELEVATION PHARMACEUTICALS INC   |  SEMNUR PHARMACEUTICALS, INC.   |  SORRENTO THERAPEUTICS, INC.   |  CELULARITY INC.   |  SCILEX HOLDING CO
LEWIS 
J. 
SHUSTER 
DIRECTOR
QUIKBYTE SOFTWARE INC   |  RESPONSE BIOMEDICAL CORP   |  PRINCIPIA BIOPHARMA INC.   |  TP THERAPEUTICS, INC.
GEORGE 
 
UY 
EXECUTIVE OFFICER
SORRENTO THERAPEUTICS, INC.   |  TRIGR THERAPEUTICS, INC.
RICHARD 
G 
VINCENT 
EXECUTIVE OFFICER
SORRENTO THERAPEUTICS, INC.
RICHARD 
G. 
VINCENT 
EXECUTIVE OFFICER, DIRECTOR
SORRENTO THERAPEUTICS, INC.   |  GENOA PHARMACEUTICALS, INC.   |  SUNEVA MEDICAL INC.
DAVID 
 
WEBB 
DIRECTOR
TYHEE DEVELOPMENT CORP   |  SORRENTO THERAPEUTICS, INC.   |  AGRAGENE, INC.
ALAN 
JAY 
WEISBERG 
EXECUTIVE OFFICER
QUIKBYTE SOFTWARE INC   |  PROGRESSIVE CARE INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-10-22
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Debt 
2013-10-21 
2013-03-28
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2013-03-13 
2012-01-11
D
Link
BIOTECHNOLOGY 
SERVICES-COMMERCIAL PHYSICAL + BIOLOGICAL RESEARCH [8731] 
DECLINE TO DISCLOSE 
Equity 
2011-12-29 
2009-09-24
D
Link
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
NO REVENUES 
Equity 
2009-09-18 
2009-09-24
D
Link
BIOTECHNOLOGY 
BLANK CHECKS [6770] 
NO REVENUES 
Equity 
2009-09-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#